Serial anitnuclear antibodies titre in pleural and pericardial fluid

D. Y. Wang, P. C. Yang, W. L. Yu, S. H. Kuo, N. Y. Hsu

研究成果: 雜誌貢獻文章

40 引文 (Scopus)

摘要

The antinuclear antibodies (ANA) test has been a cornerstone of the evaluation of connective tissue disease. The aim of this study was to investigate the diagnostic value of the ANA test in pleural or pericardial effusions of unknown causes. Over a 3-yr period, a total of 126 pleural fluid and 30 pericardial fluid samples were analysed. ANA tests were performed using a commercially available kit. The ANA kit used an indirect immunofluorescent antibody method with a human epithelial (HEP2) cell line as substrate. Patients with high fluid ANA titre (>1:160) received a second aspiration 2 weeks after the initial aspiration if diagnosis was not confirmed. ANA results were positive in 39 pleural and 10 pericardial fluid samples. All but one of the effusions with positive ANA testing were exudative. Eleven pleural or pericardial effusions due to active systematic lupus erythematosus were identified and all had high ANA titres (1:160) with various staining patterns. Thirty-eight of 145 patients (26%) with effusions of nonlupus aetiologies had positive ANA testing in pleural or pericardial fluid. Thirteen of these 38 patients had high ANA titre. Malignant or paramalignant effusions constituted 11 of the 13 samples. In conclusion, although a negative antinuclear antibodies test makes a diagnosis of lupus serositis unlikely, high antinuclear antibodies titres in pleural or pericardial fluid are not diagnostic of lupus serositis even when as high as 1:5,120. An unexplained high antinuclear antibodies titre in pleural or pericardial effusion warrants search for malignancy. (C) ERS Journals Ltd 2000.
原文英語
頁(從 - 到)1106-1110
頁數5
期刊European Respiratory Journal
15
發行號6
DOIs
出版狀態已發佈 - 2000
對外發佈Yes

指紋

Antinuclear Antibodies
Antibodies
Pericardial Effusion
Pleural Effusion
Serositis
Pericardial Fluid
Connective Tissue Diseases
Epithelial Cells

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

引用此文

Serial anitnuclear antibodies titre in pleural and pericardial fluid. / Wang, D. Y.; Yang, P. C.; Yu, W. L.; Kuo, S. H.; Hsu, N. Y.

於: European Respiratory Journal, 卷 15, 編號 6, 2000, p. 1106-1110.

研究成果: 雜誌貢獻文章

Wang, D. Y. ; Yang, P. C. ; Yu, W. L. ; Kuo, S. H. ; Hsu, N. Y. / Serial anitnuclear antibodies titre in pleural and pericardial fluid. 於: European Respiratory Journal. 2000 ; 卷 15, 編號 6. 頁 1106-1110.
@article{a38e7e50110e402cb1938ab40d669142,
title = "Serial anitnuclear antibodies titre in pleural and pericardial fluid",
abstract = "The antinuclear antibodies (ANA) test has been a cornerstone of the evaluation of connective tissue disease. The aim of this study was to investigate the diagnostic value of the ANA test in pleural or pericardial effusions of unknown causes. Over a 3-yr period, a total of 126 pleural fluid and 30 pericardial fluid samples were analysed. ANA tests were performed using a commercially available kit. The ANA kit used an indirect immunofluorescent antibody method with a human epithelial (HEP2) cell line as substrate. Patients with high fluid ANA titre (>1:160) received a second aspiration 2 weeks after the initial aspiration if diagnosis was not confirmed. ANA results were positive in 39 pleural and 10 pericardial fluid samples. All but one of the effusions with positive ANA testing were exudative. Eleven pleural or pericardial effusions due to active systematic lupus erythematosus were identified and all had high ANA titres (1:160) with various staining patterns. Thirty-eight of 145 patients (26{\%}) with effusions of nonlupus aetiologies had positive ANA testing in pleural or pericardial fluid. Thirteen of these 38 patients had high ANA titre. Malignant or paramalignant effusions constituted 11 of the 13 samples. In conclusion, although a negative antinuclear antibodies test makes a diagnosis of lupus serositis unlikely, high antinuclear antibodies titres in pleural or pericardial fluid are not diagnostic of lupus serositis even when as high as 1:5,120. An unexplained high antinuclear antibodies titre in pleural or pericardial effusion warrants search for malignancy. (C) ERS Journals Ltd 2000.",
keywords = "Antinuclear antibodies, Pericardial effusion, Pleural effusion",
author = "Wang, {D. Y.} and Yang, {P. C.} and Yu, {W. L.} and Kuo, {S. H.} and Hsu, {N. Y.}",
year = "2000",
doi = "10.1034/j.1399-3003.2000.01520.x",
language = "English",
volume = "15",
pages = "1106--1110",
journal = "European Respiratory Journal",
issn = "0903-1936",
publisher = "European Respiratory Society",
number = "6",

}

TY - JOUR

T1 - Serial anitnuclear antibodies titre in pleural and pericardial fluid

AU - Wang, D. Y.

AU - Yang, P. C.

AU - Yu, W. L.

AU - Kuo, S. H.

AU - Hsu, N. Y.

PY - 2000

Y1 - 2000

N2 - The antinuclear antibodies (ANA) test has been a cornerstone of the evaluation of connective tissue disease. The aim of this study was to investigate the diagnostic value of the ANA test in pleural or pericardial effusions of unknown causes. Over a 3-yr period, a total of 126 pleural fluid and 30 pericardial fluid samples were analysed. ANA tests were performed using a commercially available kit. The ANA kit used an indirect immunofluorescent antibody method with a human epithelial (HEP2) cell line as substrate. Patients with high fluid ANA titre (>1:160) received a second aspiration 2 weeks after the initial aspiration if diagnosis was not confirmed. ANA results were positive in 39 pleural and 10 pericardial fluid samples. All but one of the effusions with positive ANA testing were exudative. Eleven pleural or pericardial effusions due to active systematic lupus erythematosus were identified and all had high ANA titres (1:160) with various staining patterns. Thirty-eight of 145 patients (26%) with effusions of nonlupus aetiologies had positive ANA testing in pleural or pericardial fluid. Thirteen of these 38 patients had high ANA titre. Malignant or paramalignant effusions constituted 11 of the 13 samples. In conclusion, although a negative antinuclear antibodies test makes a diagnosis of lupus serositis unlikely, high antinuclear antibodies titres in pleural or pericardial fluid are not diagnostic of lupus serositis even when as high as 1:5,120. An unexplained high antinuclear antibodies titre in pleural or pericardial effusion warrants search for malignancy. (C) ERS Journals Ltd 2000.

AB - The antinuclear antibodies (ANA) test has been a cornerstone of the evaluation of connective tissue disease. The aim of this study was to investigate the diagnostic value of the ANA test in pleural or pericardial effusions of unknown causes. Over a 3-yr period, a total of 126 pleural fluid and 30 pericardial fluid samples were analysed. ANA tests were performed using a commercially available kit. The ANA kit used an indirect immunofluorescent antibody method with a human epithelial (HEP2) cell line as substrate. Patients with high fluid ANA titre (>1:160) received a second aspiration 2 weeks after the initial aspiration if diagnosis was not confirmed. ANA results were positive in 39 pleural and 10 pericardial fluid samples. All but one of the effusions with positive ANA testing were exudative. Eleven pleural or pericardial effusions due to active systematic lupus erythematosus were identified and all had high ANA titres (1:160) with various staining patterns. Thirty-eight of 145 patients (26%) with effusions of nonlupus aetiologies had positive ANA testing in pleural or pericardial fluid. Thirteen of these 38 patients had high ANA titre. Malignant or paramalignant effusions constituted 11 of the 13 samples. In conclusion, although a negative antinuclear antibodies test makes a diagnosis of lupus serositis unlikely, high antinuclear antibodies titres in pleural or pericardial fluid are not diagnostic of lupus serositis even when as high as 1:5,120. An unexplained high antinuclear antibodies titre in pleural or pericardial effusion warrants search for malignancy. (C) ERS Journals Ltd 2000.

KW - Antinuclear antibodies

KW - Pericardial effusion

KW - Pleural effusion

UR - http://www.scopus.com/inward/record.url?scp=0033623953&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033623953&partnerID=8YFLogxK

U2 - 10.1034/j.1399-3003.2000.01520.x

DO - 10.1034/j.1399-3003.2000.01520.x

M3 - Article

C2 - 10885431

AN - SCOPUS:0033623953

VL - 15

SP - 1106

EP - 1110

JO - European Respiratory Journal

JF - European Respiratory Journal

SN - 0903-1936

IS - 6

ER -